Montreal, Canada

Djordje Ajdukovic


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Montreal, CA (1976 - 1981)
  • Beaconsfield, CA (1982)

Company Filing History:


Years Active: 1976-1982

Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Djordje Ajdukovic in Antiviral Research**

Introduction

Djordje Ajdukovic, based in Montreal, Canada, is a distinguished inventor with a noteworthy portfolio of seven patents. His contributions primarily focus on the development of antiviral compounds, showcasing his commitment to enhancing therapeutic options for viral infections, particularly those affecting warm-blooded animals.

Latest Patents

Ajdukovic's latest patents include groundbreaking formulations targeting viral infections. One significant patent covers derivatives of 1,2,3,4-tetrahydro-1,4-methanonaphthalene, highlighting their application in controlling the influenza virus. These derivatives come in pharmaceutical compositions that integrate an antiviral effective amount alongside a pharmaceutically acceptable carrier. His other notable patent involves therapeutic compositions of 5-(substituted benzal) hydantoins, aimed at tackling virus infections caused by entero and foot-and-mouth disease viruses from the Picorna group. Each of these inventions underscores his innovative approach to virology.

Career Highlights

Throughout his career, Djordje Ajdukovic has worked with reputable organizations such as Canada Packers Inc. and the Institute of Microbiology and Hygiene of the University of Montreal. His experience in these institutions has provided him with practical insight into the intricacies of microbiological research and product development. Ajdukovic’s expertise has played a critical role in advancing antiviral research, further establishing his reputation in the field.

Collaborations

Ajdukovic has collaborated with prominent professionals in his field, including Kekhusroo R. Bharucha and Vytautas Pavilanis. These collaborations have facilitated the sharing of knowledge and resources, further fueling innovation in antiviral therapies. Together, they contribute to a robust body of research that aims to improve health outcomes in veterinary medicine.

Conclusion

Djordje Ajdukovic stands as a prominent figure in the realm of antiviral research, with a patent portfolio that reflects his dedication to combating viral infections. His innovative contributions are vital in the pursuit of effective treatments and highlight the importance of collaboration in scientific advancements. As he continues to develop novel compounds, Ajdukovic's work may pave the way for future breakthroughs in virology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…